Hypertension in the syndrome of apparent mineralocorticoid excess due to mutation of the 11β-hydroxysteroid dehydrogenase type 2 gene
- 1 January 1996
- journal article
- case report
- Published by Elsevier in The Lancet
- Vol. 347 (8994) , 88-91
- https://doi.org/10.1016/s0140-6736(96)90211-1
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Detection of human 11β-hydroxysteroid dehydrogenase isoforms using reverse-transcriptase-polymerase chain reaction and localization of the type 2 isoform to renal collecting ductsMolecular and Cellular Endocrinology, 1995
- Evidence of Coexisting Changes in 11β-Hydroxysteroid Dehydrogenase and 5β-Reductase Activity in Subjects With Untreated Essential HypertensionHypertension, 1995
- Localization of the gene for human 11β-hydroxysteroid dehydrogenase type 2 (HSD11B2) to chromosome band 16q22Cytogenetic and Genome Research, 1995
- Cloning and tissue distribution of the human 1 lβ-hydroxysteroid dehydrogenase type 2 enzymeMolecular and Cellular Endocrinology, 1994
- Deficient inactivation of cortisol by 11β‐hydroxysteroid dehydrogenase in essential hypertensionClinical Endocrinology, 1993
- A chimaeric llβ-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertensionNature, 1992
- LOCALISATION OF 11β-HYDROXYSTEROID DEHYDROGENASE—TISSUE SPECIFIC PROTECTOR OF THE MINERALOCORTICOID RECEPTORThe Lancet, 1988
- Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle.Journal of Clinical Investigation, 1988
- MINERALOCORTICOID ACTIVITY OF LIQUORICE: 11-BETA-HYDROXYSTEROID DEHYDROGENASE DEFICIENCY COMES OF AGEThe Lancet, 1987
- NEW FINDINGS IN APPARENT MINERALOCORTICOID EXCESSClinical Endocrinology, 1987